Xtant Medical Announces OrbiMed Share Sale, Q1 2025 Revenue Growth
Healthcare Focused Long-term Investors Support Strategic Vision Accelerating Shift to Higher-Margin Orthobiologics Supported by New Product Launches Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global...